3 Health Services Stocks Driving The Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 7 points (0.0%) at 16,563 as of Tuesday, Aug. 12, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,349 issues advancing vs. 1,605 declining with 179 unchanged.

The Health Services industry currently sits down 0.1% versus the S&P 500, which is down 0.1%. Top gainers within the industry include Smith & Nephew ( SNN), up 1.6%, Intuitive Surgical ( ISRG), up 1.4%, WellPoint ( WLP), up 0.9%, Cigna ( CI), up 0.8% and Boston Scientific ( BSX), up 0.5%. On the negative front, top decliners within the industry include Abbott Laboratories ( ABT), down 1.2%, Fresenius Medical Care AG & Co. KGaA ( FMS), down 1.1%, HCA Holdings ( HCA), down 0.7%, St Jude Medical ( STJ), down 0.6% and Aetna ( AET), down 0.5%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Charles River Laboratories International In ( CRL) is one of the companies pushing the Health Services industry higher today. As of noon trading, Charles River Laboratories International In is up $1.62 (2.9%) to $58.37 on heavy volume. Thus far, 330,812 shares of Charles River Laboratories International In exchanged hands as compared to its average daily volume of 425,200 shares. The stock has ranged in price between $56.76-$58.48 after having opened the day at $56.81 as compared to the previous trading day's close of $56.75.

Charles River Laboratories International, Inc., together with its subsidiaries, provides research models and associated services, and outsourced preclinical services to accelerate the drug discovery and development process. Charles River Laboratories International In has a market cap of $2.7 billion and is part of the health care sector. Shares are up 7.0% year-to-date as of the close of trading on Monday. Currently there are 5 analysts who rate Charles River Laboratories International In a buy, no analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates Charles River Laboratories International In as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Charles River Laboratories International In Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Varian Medical Systems ( VAR) is up $0.70 (0.8%) to $85.48 on average volume. Thus far, 252,536 shares of Varian Medical Systems exchanged hands as compared to its average daily volume of 558,300 shares. The stock has ranged in price between $84.31-$85.51 after having opened the day at $84.71 as compared to the previous trading day's close of $84.78.

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy worldwide. Varian Medical Systems has a market cap of $8.8 billion and is part of the health care sector. Shares are up 9.1% year-to-date as of the close of trading on Monday. Currently there are 6 analysts who rate Varian Medical Systems a buy, 1 analyst rates it a sell, and none rate it a hold.

TheStreet Ratings rates Varian Medical Systems as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Varian Medical Systems Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, DaVita HealthCare Partners ( DVA) is up $0.49 (0.7%) to $72.28 on light volume. Thus far, 235,388 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 887,900 shares. The stock has ranged in price between $71.65-$72.36 after having opened the day at $71.81 as compared to the previous trading day's close of $71.79.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease. It operates kidney dialysis centers and provides related lab services primarily in outpatient dialysis centers and in contracted hospitals. DaVita HealthCare Partners has a market cap of $15.4 billion and is part of the health care sector. Shares are up 13.3% year-to-date as of the close of trading on Monday. Currently there are 8 analysts who rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full DaVita HealthCare Partners Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Video: You Could Live in a Ritz-Carlton or St. Regis Home

Video: You Could Live in a Ritz-Carlton or St. Regis Home